Mukka Proteins Complete Financial Statements
In FY2026, Mukka Proteins (MUKKA) reported revenue ₹383 Cr, net profit ₹21 Cr and EPS ₹0.69, with a net profit margin of 5.5% and ROE of 4.2%. Full financial statements from FY2019 to FY2026 (8 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore MUKKA value investing to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
MUKKA Revenue, Net Profit & EBITDA — Year-on-Year Growth
MUKKA YoY (Mar 2025 vs Mar 2026) — revenue +1.9%, net profit +50.0%, EBITDA +54.2%, expenses -1.7%. For live price, earnings ratios and company overview, see MUKKA share price.
MUKKA Income Statement — Revenue, EBITDA & Net Profit
Mukka Proteins revenue ₹383 Cr, EBITDA ₹37 Cr, net profit ₹21 Cr, EPS ₹0.69 (2026) — net profit margin 5.5%. Review Mukka Proteins price earnings to evaluate earnings-based valuation against sector peers.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 383 | 242 | 376 | 167 | 642 | 149 | 255 | 170 | 303 | 331 | 409 | 269 | 510 | 397 |
| Expenses | 347 | 224 | 353 | 157 | 608 | 140 | 225 | 159 | 262 | 294 | 378 | 260 | 498 | 362 |
| EBITDA | 37 | 18 | 24 | 11 | 34 | 9 | 30 | 11 | 41 | 37 | 31 | 9 | 12 | 34 |
| Operating Profit Margin % | 6.00% | 5.00% | 5.00% | 5.00% | 4.00% | 4.00% | 10.00% | 5.00% | 12.00% | 9.00% | 8.00% | 2.00% | 1.00% | 8.00% |
| Depreciation | 5 | 4 | 3 | 3 | 4 | 4 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 |
| Interest | 15 | 13 | 10 | 11 | 15 | 9 | 7 | 8 | 11 | 6 | 7 | 6 | 6 | 4 |
| Profit Before Tax | 29 | 9 | 20 | 2 | 35 | 1 | 27 | 6 | 33 | 35 | 33 | 8 | 18 | 33 |
| Tax | 8 | 2 | 6 | 1 | 7 | 0 | -2 | 0 | 6 | 6 | 11 | 4 | 5 | 6 |
| Net Profit | 21 | 7 | 14 | 2 | 27 | 2 | 29 | 5 | 27 | 29 | 22 | 4 | 12 | 27 |
| Earnings Per Share (₹) | 0.69 | 0.20 | 0.45 | 0.05 | 0.79 | 0.07 | 1.20 | 0.14 | 0.88 | 1.29 | 0.99 | 0.16 | 0.48 | 1.03 |
MUKKA Balance Sheet — Assets, Liabilities & Shareholders' Equity
MUKKA total assets ₹1,621 Cr, total equity ₹499 Cr, total liabilities ₹ Cr (2026) — ROE 4.2%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Total Assets | 1,621 | 1,076 | 941 | 575 | 392 | 355 | 293 | 201 |
| Current Assets | 1,289 | 926 | 817 | 464 | 286 | 257 | 206 | 142 |
| Fixed Assets | 210 | 94 | 85 | 85 | 83 | 79 | 78 | 49 |
| Capital Work in Progress | 31 | 9 | 0 | 0 | 0 | 4 | 2 | 0 |
| Investments | 857 | 37 | 31 | 21 | 21 | 12 | 4 | 8 |
| Other Assets | 0 | 937 | 825 | 469 | 289 | 260 | 209 | 144 |
| LIABILITIES | ||||||||
| Total Liabilities | ||||||||
| Current Liabilities | 43 | 9 | 12 | 17 | 15 | 13 | 18 | 20 |
| Non-Current Liabilities | ||||||||
| SHAREHOLDERS' EQUITY | ||||||||
| Total Equity | 499 | 457 | 408 | 156 | 103 | 70 | 58 | 44 |
| Share Capital | 30 | 30 | 30 | 22 | 22 | 6 | 6 | 6 |
| Reserves & Surplus | 469 | 411 | 366 | 126 | 76 | 61 | 51 | 39 |
MUKKA Cash Flow Statement — Operating, Investing & Financing
Mukka Proteins operating cash flow ₹-112 Cr, investing ₹-35 Cr, financing ₹56 Cr, net cash flow ₹-91 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | -112 | -150 | -56 | 5 | 2 | -25 | -20 |
| Investing Activities | -35 | -48 | -3 | -12 | -14 | -28 | -23 |
| Financing Activities | 56 | 266 | 75 | 15 | 14 | 54 | 34 |
| Net Cash Flow | -91 | 68 | 15 | 8 | 2 | 1 | -9 |